KIRTI SAXENA to Prospective Studies
This is a "connection" page, showing publications KIRTI SAXENA has written about Prospective Studies.
Connection Strength
0.049
-
Divalproex sodium-ER in outpatients with disruptive behavior disorders: a three month open label study. Child Psychiatry Hum Dev. 2010 Jun; 41(3):274-84.
Score: 0.041
-
An open-label study of lamotrigine adjunct or monotherapy for the treatment of adolescents with bipolar depression. J Am Acad Child Adolesc Psychiatry. 2006 Mar; 45(3):298-304.
Score: 0.008